... Gazyva (obinutuzumab), Rituxan (rituximab), and Arzerra (ofatumumab) are monoclonal antibodies that have been FDA-approved to fight CLL. In some cases, they are a part of initial treatment. ...
... Gazyva (obinutuzumab), Rituxan (rituximab), and Arzerra (ofatumumab) are monoclonal antibodies that have been FDA-approved to fight CLL. In some cases, they are a part of initial treatment. ...
... Monoclonal antibodies that are used to treat CLL include: Arzerra (ofatumumab) Gazyva (obinutuzumab) Rituxan (rituximab) Combining Cancer TreatmentsOften, your doctor will recommend that you use a combination of targeted therapy and chemotherapy drugs. ...
... Monoclonal antibodies that are used to treat CLL include: Arzerra (ofatumumab) Gazyva (obinutuzumab) Rituxan (rituximab) Combining Cancer TreatmentsOften, your doctor will recommend that you use a combination of targeted therapy and chemotherapy drugs. ...